gns561
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Apr 4, 2018 (NCT03316222)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)(C)NC1CCN(c2cc(NCc3ccc(Cl)cc3)nc3ccccc23)CC1- Mol. weight
- 423 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095179 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05874414 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2023 | Genfit |
| NCT05448677 | Phase 2 | Dec 15, 2022 | Genoscience Pharma, University of Grenoble |
| NCT05353894 | Phase 1 | May 2, 2022 | Genoscience Pharma |
| NCT04637828 | Phase 2 | Nov 18, 2020 | Genoscience Pharma |
| NCT03316222 | Phase 1/Phase 2 (Phase 2) | Apr 4, 2018 | Genoscience Pharma |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genoscience Pharma | For profit | 4 | 3 | 2 | 2018 |
| Genfit | For profit | 1 | 1 | 1 | 2023 |
| University of Grenoble | Academic/Hospital | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1